⚡ 𝐔𝐏𝐃𝐀𝐓𝐄: $Tempus AI(TEM.US) Tempus AI Launches 𝐓𝐞𝐦𝐩𝐮𝐬 𝐏𝐫𝐞𝐯𝐢𝐞𝐰 for Faster Cancer Insights
👉 𝐊𝐞𝐲 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬:➤ Tempus AI unveils 𝐓𝐞𝐦𝐩𝐮𝐬 𝐏𝐫𝐞𝐯𝐢𝐞𝐰 for rapid oncology decision support.➤ Application delivers preliminary biomarker insights within ~𝟐𝟒 𝐡𝐨𝐮𝐫𝐬 of tissue receipt.➤ AI helps bridge the gap before full 𝐠𝐞𝐧𝐨𝐦𝐢𝐜 𝐬𝐞𝐪𝐮𝐞𝐧𝐜𝐢𝐧𝐠 results arrive.➤ Initial focus includes 𝐌𝐒𝐈-𝐇, 𝐄𝐆𝐅𝐑 mutations, and 𝐅𝐆𝐅𝐑 fusions.➤ Early insights may accelerate 𝐩𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐳𝐞𝐝 𝐜𝐚𝐧𝐜𝐞𝐫 treatment planning.➤ Predictions powered by 𝐏𝐚𝐢𝐠𝐞 𝐏𝐫𝐞𝐝𝐢𝐜𝐭 AI trained on millions of slides.➤ Expands Tempus’ use of 𝐀𝐈-𝐝𝐫𝐢𝐯𝐞𝐧 precision medicine in clinical workflowsThe copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments